◑ We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

Addex Therapeutics Ltd

CH0029850754 · ADXNSIX ·

CH · Healthcare · Stock

Addex Therapeutics Ltd is a Swiss clinical-stage biopharmaceutical company headquartered in Geneva, focused on developing allosteric modulators as a novel class of small-molecule drugs. The company's pipeline targets neurological and addiction disorders, with key programs centered on GABAB receptor positive allosteric modulators for conditions such as alcohol use disorder and Charcot-Marie-Tooth disease. Addex is listed on the SIX Swiss Exchange and has pursued partnerships to advance its proprietary drug discovery platform.

Dividend Yield

—

TTM · SIX

Last Dividend

—

CHF

5Y Growth

—

CAGR

Frequency

None

Years Paid

—

consecutive

Not Cut

—

consecutive yrs

Grown

—

consecutive yrs

Listings

Exchange	Ticker	Currency	Yield TTM
SIX	ADXN	CHF	—

Total Return

Starting Amount 10'000 CHF

Price Gain −2'612 CHF

Dividends —

Total Return -26.12%

CAGR -26.13%

End Balance 7'388 CHF

Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.

Annual Dividends

No dividend history available.

Dividend Yield History

Loading yield history…

ⓘ

Dividend History

Ex-Date ▼	Pay-Date ▼	Amount ▼	Type ▼
No dividend events found.